|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,100.00 DKK | -0.85% |
|
-3.98% | +3.50% |
| 21/01 | DNB Carnegie Upgrades Genmab to Buy, Raises PT | MT |
| 21/01 | Genmab Posts Higher Darzalex Net Sales in FY25 | MT |
| Capitalization | 13TCr 2.05TCr 1.75TCr 1.62TCr 1.52TCr 2.83TCr 1,87900Cr 3TCr 19TCr 7.34TCr 89TCr 7.69TCr 7.53TCr 3,24700Cr | P/E ratio 2025 * |
18x | P/E ratio 2026 * | 20.5x |
|---|---|---|---|---|---|
| Enterprise value | 11TCr 1.67TCr 1.42TCr 1.32TCr 1.24TCr 2.3TCr 1,53000Cr 2.44TCr 15TCr 5.97TCr 72TCr 6.26TCr 6.14TCr 2,64400Cr | EV / Sales 2025 * |
4.47x | EV / Sales 2026 * | 3.69x |
| Free-Float |
95.94% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Genmab A/S
| 1 day | -0.85% | ||
| 1 week | -3.98% | ||
| Current month | +3.50% | ||
| 1 month | -1.18% | ||
| 3 months | +8.26% | ||
| 6 months | +44.74% | ||
| Current year | +3.50% |
| 1 week | 1,976 |  | 2,130 |
| 1 month | 1,976 | | 2,257 |
| Current year | 1,976 | | 2,257 |
| 1 year | 1,157 | | 2,257 |
| 3 years | 1,157 | | 2,947 |
| 5 years | 1,157 | | 3,327 |
| 10 years | 605.5 | | 3,327 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 01/06/2010 | |
Anthony Pagano
DFI | Director of Finance/CFO | 48 | 01/03/2020 |
Rayne Waller
CTO | Chief Tech/Sci/R&D Officer | - | 16/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 75 | 01/11/2003 | |
| Director/Board Member | 59 | 01/01/2015 | |
| Director/Board Member | 75 | 01/01/2015 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +5.13% | 3.64% | 1,470 M€ | |
| +0.75% | 0.75% | 26 M€ | |
| +2.91% | 0.56% | 1,143 M€ | |
| +1.76% | 0.45% | 31 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.85% | -3.98% | +38.76% | -22.90% | 2.05TCr | |
| +0.40% | +1.18% | +13.45% | +93.33% | 5.03TCr | |
| -0.96% | -5.76% | +78.85% | +0.10% | 4.18TCr | |
| +2.60% | +0.70% | +104.45% | +668.15% | 3.42TCr | |
| +0.40% | +11.69% | +2.87% | -17.03% | 2.97TCr | |
| +0.92% | -1.16% | +123.92% | -44.93% | 2.07TCr | |
| +3.65% | -3.72% | +91.30% | +130.69% | 1.33TCr | |
| +3.09% | +0.58% | -26.15% | +295.67% | 1.34TCr | |
| +3.07% | -9.33% | +163.56% | - | 1.25TCr | |
| -0.69% | -2.07% | +35.34% | +165.99% | 1.2TCr | |
| Average | +1.16% | -1.92% | +62.63% | +141.01% | 2.48TCr | |
| Weighted average by Cap. | +0.81% | -0.98% | +57.63% | +141.37% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.38TCr 373.83Cr 318.16Cr 295.49Cr 277.04Cr 515.88Cr 34TCr 546.95Cr 3.37TCr 1.34TCr 16TCr 1.4TCr 1.37TCr 59TCr | 2.76TCr 434.17Cr 369.52Cr 343.19Cr 321.76Cr 599.15Cr 40TCr 635.24Cr 3.92TCr 1.55TCr 19TCr 1.63TCr 1.59TCr 69TCr |
| Net income | 750.83Cr 118.04Cr 100.46Cr 93Cr 87Cr 162.9Cr 11TCr 172.71Cr 1.07TCr 422.13Cr 5.11TCr 442.64Cr 433.58Cr 19TCr | 706.68Cr 111.1Cr 95Cr 88Cr 82Cr 153.32Cr 10TCr 162.55Cr 1TCr 397.31Cr 4.81TCr 416.61Cr 408.08Cr 18TCr |
| Net Debt | -2.42TCr -380.85Cr -324.14Cr -301.04Cr -282.25Cr -525.57Cr -35TCr -557.23Cr -3.44TCr -1.36TCr -16TCr -1.43TCr -1.4TCr -60TCr | -2.85TCr -447.9Cr -381.2Cr -354.04Cr -331.94Cr -618.09Cr -41TCr -655.32Cr -4.04TCr -1.6TCr -19TCr -1.68TCr -1.65TCr -71TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/26/23 | 2,095.00 kr | -1.09% | 14,669 |
| 22/26/22 | 2,118.00 kr | +1.44% | 94,797 |
| 21/26/21 | 2,088.00 kr | +4.50% | 1,52,501 |
| 20/26/20 | 1,998.00 kr | -2.20% | 1,51,930 |
| 19/26/19 | 2,043.00 kr | -6.50% | 1,85,083 |
Delayed Quote Nasdaq Copenhagen, January 23, 2026 at 04:32 pm IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GMAB Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition